Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types

PURPOSE: To explore relationships between biological gene expression signatures and pembrolizumab response. EXPERIMENTAL DESIGN: RNA-sequencing data on baseline tumor tissue from 1,188 patients across seven tumor types treated with pembrolizumab monotherapy in nine clinical trials were used. A total...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristescu, Razvan, Nebozhyn, Michael, Zhang, Chunsheng, Albright, Andrew, Kobie, Julie, Huang, Lingkang, Zhao, Qing, Wang, Anran, Ma, Hua, Alexander Cao, Z., Morrissey, Michael, Ribas, Antoni, Grivas, Petros, Cescon, David W., McClanahan, Terrill K., Snyder, Alexandra, Ayers, Mark, Lunceford, Jared, Loboda, Andrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762333/
https://www.ncbi.nlm.nih.gov/pubmed/34965943
http://dx.doi.org/10.1158/1078-0432.CCR-21-3329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762333/
https://www.ncbi.nlm.nih.gov/pubmed/34965943
http://dx.doi.org/10.1158/1078-0432.CCR-21-3329

Ejemplares similares